KRAMPERA, Mauro
 Distribuzione geografica
Continente #
EU - Europa 17.614
NA - Nord America 16.801
AS - Asia 10.747
SA - Sud America 1.477
AF - Africa 223
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 20
AN - Antartide 1
Totale 46.934
Nazione #
US - Stati Uniti d'America 16.453
RU - Federazione Russa 7.023
SG - Singapore 3.906
CN - Cina 3.857
GB - Regno Unito 3.459
IT - Italia 1.593
BR - Brasile 1.205
DE - Germania 1.097
HK - Hong Kong 982
SE - Svezia 971
FR - Francia 970
IE - Irlanda 872
FI - Finlandia 793
VN - Vietnam 664
KR - Corea 370
UA - Ucraina 226
IN - India 188
CA - Canada 184
JP - Giappone 167
AR - Argentina 115
MX - Messico 115
ID - Indonesia 112
BE - Belgio 99
NL - Olanda 87
PL - Polonia 84
TR - Turchia 84
ES - Italia 83
IR - Iran 78
BD - Bangladesh 69
AT - Austria 68
ZA - Sudafrica 57
EC - Ecuador 49
IQ - Iraq 47
AU - Australia 45
BJ - Benin 36
LT - Lituania 32
CO - Colombia 26
MA - Marocco 26
PK - Pakistan 26
UZ - Uzbekistan 26
CL - Cile 25
TG - Togo 23
EG - Egitto 22
RO - Romania 21
MY - Malesia 20
CH - Svizzera 19
VE - Venezuela 18
AZ - Azerbaigian 17
AE - Emirati Arabi Uniti 16
CZ - Repubblica Ceca 16
EU - Europa 16
KE - Kenya 16
PY - Paraguay 16
IL - Israele 15
PT - Portogallo 14
PE - Perù 12
BG - Bulgaria 11
CM - Camerun 11
KZ - Kazakistan 10
SA - Arabia Saudita 10
GR - Grecia 9
KG - Kirghizistan 9
PH - Filippine 9
AL - Albania 8
LV - Lettonia 8
CR - Costa Rica 7
DK - Danimarca 7
PA - Panama 7
TH - Thailandia 7
TN - Tunisia 7
UY - Uruguay 7
NO - Norvegia 6
TW - Taiwan 6
AM - Armenia 5
CG - Congo 5
DZ - Algeria 5
HN - Honduras 5
HU - Ungheria 5
JM - Giamaica 5
LA - Repubblica Popolare Democratica del Laos 5
NI - Nicaragua 5
RS - Serbia 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
JO - Giordania 4
LU - Lussemburgo 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CI - Costa d'Avorio 3
CY - Cipro 3
GE - Georgia 3
GT - Guatemala 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
Totale 46.876
Città #
Southend 2.971
Moscow 2.410
Dallas 2.299
Jacksonville 1.958
Chandler 1.930
Singapore 1.690
Ashburn 1.374
Woodbridge 1.225
Hong Kong 971
Ann Arbor 885
Dublin 865
Houston 696
Beijing 579
New York 390
Verona 363
The Dalles 355
Los Angeles 331
Jinan 324
Lawrence 314
Princeton 314
Wilmington 305
Shenyang 299
Nanjing 261
Munich 249
Ho Chi Minh City 215
Buffalo 170
Tianjin 164
Helsinki 155
Milan 151
Hebei 140
São Paulo 136
Sindelfingen 130
Hanoi 117
Zhengzhou 113
Changsha 107
Columbus 107
Redondo Beach 105
Turku 103
Santa Clara 98
Nanchang 97
Brussels 93
Haikou 91
Ningbo 86
Seoul 86
Düsseldorf 85
Tokyo 84
Hangzhou 83
Guangzhou 80
Redmond 79
Boardman 77
London 76
Seattle 74
Warsaw 74
Taiyuan 72
Taizhou 71
Dong Ket 70
San Francisco 66
Jiaxing 65
Novosibirsk 64
Montreal 62
Jakarta 61
Lancaster 59
Brooklyn 58
Denver 57
Council Bluffs 54
Chicago 53
Frankfurt am Main 53
Rome 52
Stockholm 52
Bologna 49
Norwalk 46
Chennai 45
Toronto 44
Atlanta 43
Mexico City 42
Orem 42
Boston 41
Johannesburg 41
Rio de Janeiro 40
Vienna 39
Auburn Hills 38
Fairfield 38
Lanzhou 38
Lappeenranta 38
Cotonou 36
Kent 35
Nuremberg 33
Dearborn 31
Falkenstein 31
Fuzhou 31
Phoenix 31
Redwood City 29
Poplar 28
Falls Church 27
Washington 27
Amsterdam 26
Brasília 26
Mumbai 26
Tehran 26
Belo Horizonte 25
Totale 28.595
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 456
Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog 378
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 310
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 283
Comparative Study of Immune Regulatory Properties of Stem Cells Derived from Different Tissues. 278
Risk Factors for Persisting SARS-CoV-2 Infection in Patients with B-Cell Malignancies in the Omicron Era: A Multicenter Cohort Study 274
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 272
Meninges: from protective membrane to stem cell niche 259
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 258
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 251
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 242
Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. 240
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. 237
In vitro characterization of the differentiation of meningeal Stem/precursor cells into the oligodendrocyte lineage 233
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 228
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 228
IN VITRO CHARACTERIZATION OF THE DIFFERENTIATION OF MENINGEAL STEM/PRECURSOR CELLS INTO THE OLIGODENDROCYTE LINEAGE 222
Quantitative fluorescence in situ hybridization on paraffin embedded tissue. 222
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 222
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 221
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 220
Meninges as a niche for stem/precursor cells with neural differentiation potential during development up to adulthood. 217
A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 216
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 216
Migration of meningeal cells in response to contusive spinal cord injury 215
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 213
Adult spinal cord meninges: A new source of neural stem cells 213
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 211
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 210
Adipose derived mesenchimal stem cells and CNS: differentiation potential and immune suppression 207
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 207
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 207
Adipose-derived stromal cells (ASCs) 206
In vitro characterization of the differentiation of meningeal stem/precursor cells into the oligodendrocyte lineage 204
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 201
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 201
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 201
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 197
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 197
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 195
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 193
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 193
Domanda di brevetto per modello di utilità nr. TO2010U000026 depositata il 23 Febbraio 2010 dal titolo: "DISPOSITIVO PER LA COLTURA CELLULARE", poi convertito in brevetto modello nazionale (nr. 272134) ed internazionale (PCT/IB2011/000365). 192
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 192
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 190
Acute Myeloid Leukemia (AML) after BMT in a patient with Acute T-Lymphoblastic Leukemia (T-ALL) in CR, with no detectable minimal residual disease by flow-cytometry 189
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 189
Clinical treatment of radiotherapy tissue damages by lipoaspirates transplant: a healing process mediated by adipose-derived adult stem cells (ASCs) 187
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 186
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 186
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 184
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 183
A murine model for the study of the inhibitory effect on antigen-specific naïve and memory T cells by bone marrow mesenchymal stem cells 181
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 181
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 180
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 180
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 179
Meninges harbor cells expressing neural precursor markers during development and adulthood 175
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 172
Guided differentiation of MSCs for regeneration of perimplant bone 172
Regenerative potential of leptomeningeal-derived oligodendrocytes in rat model of spinal cord injury 170
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 170
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 170
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 169
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 169
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 168
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice 168
Chapter 4: Mesenchymal stem cell isolation and expansion methodology. In: Stem Cells And Cancer Stem Cells: Therapeutic Applications in Disease and Injury 168
Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment 168
Effects of a Ceramic Biomaterial on Immune Modulatory Properties and Differentiation Potential of Human Mesenchymal Stromal Cells of Different Origin. 168
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 167
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 167
Preventive and therapeutic beneficial effect of adipose-derived mesenchymal stem cells in chronic EAE 166
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 166
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 166
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 166
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 164
Immune Modulation by Mesenchymal Stem Cells 164
Differentiation of mature oligodendrocytes from small biopsy of adult rat spinal cord meninges 164
P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin’s lymphomas and Hodgkin’s disease: a reliable marker of p53 tumor suppressor gene function 164
Adipose-derived mesenchymal stem cells maintains their stem profile with aging. 163
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions 163
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 162
Stem molecular signature of adipose-derived stromal cells. 161
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 161
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 161
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 160
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 160
Homing and migration of transplanted leptomeningeal stem/progenitor cells in adult rat brain 160
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 160
Adult T-cell acute lymphoblastic leucemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol 159
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia 159
Multipotent stem cell with neural differentiation potential reside in the leptomeninges 158
Inhibition of Notch signaling enhances chemosensitivity in B cell precursor acute lymphoblastic leukemia 158
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients 158
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies? 157
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 157
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 156
Sequential high dose chemotherapy with PBSC rescue in advanced hematologic malignancies 156
Nestin- and Doublecortin-Positive Cells Reside in Adult Spinal CordMeninges and Participate in Injury-Induced Parenchymal Reaction 155
Totale 19.678
Categoria #
all - tutte 151.030
article - articoli 85.569
book - libri 0
conference - conferenze 62.312
curatela - curatele 0
other - altro 474
patent - brevetti 715
selected - selezionate 0
volume - volumi 1.960
Totale 302.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.394 0 0 0 0 0 351 47 218 203 32 358 185
2021/20222.615 304 707 38 175 120 54 31 154 102 92 234 604
2022/20235.503 405 565 509 1.047 455 1.336 30 327 569 47 133 80
2023/20243.038 110 211 257 303 339 502 191 175 33 207 475 235
2024/20257.624 440 493 360 1.202 364 277 311 300 1.210 476 712 1.479
2025/202615.662 1.538 1.741 1.872 3.848 6.354 309 0 0 0 0 0 0
Totale 47.372